APGE
Price
$47.46
Change
+$3.14 (+7.08%)
Updated
Jul 3 closing price
Capitalization
2.77B
57 days until earnings call
MLYS
Price
$14.54
Change
+$0.24 (+1.68%)
Updated
Jul 3 closing price
Capitalization
947.65M
36 days until earnings call
Interact to see
Advertisement

APGE vs MLYS

Header iconAPGE vs MLYS Comparison
Open Charts APGE vs MLYSBanner chart's image
Apogee Therapeutics
Price$47.46
Change+$3.14 (+7.08%)
Volume$507.96K
Capitalization2.77B
Mineralys Therapeutics
Price$14.54
Change+$0.24 (+1.68%)
Volume$349.92K
Capitalization947.65M
APGE vs MLYS Comparison Chart in %
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. MLYS commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and MLYS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (APGE: $47.46 vs. MLYS: $14.54)
Brand notoriety: APGE and MLYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 69% vs. MLYS: 42%
Market capitalization -- APGE: $2.77B vs. MLYS: $947.65M
APGE [@Biotechnology] is valued at $2.77B. MLYS’s [@Biotechnology] market capitalization is $947.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileMLYS’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • MLYS’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than MLYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 5 TA indicator(s) are bullish while MLYS’s TA Score has 5 bullish TA indicator(s).

  • APGE’s TA Score: 5 bullish, 4 bearish.
  • MLYS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, APGE is a better buy in the short-term than MLYS.

Price Growth

APGE (@Biotechnology) experienced а +8.33% price change this week, while MLYS (@Biotechnology) price change was +3.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

APGE is expected to report earnings on Sep 01, 2025.

MLYS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.77B) has a higher market cap than MLYS($948M). MLYS YTD gains are higher at: 18.115 vs. APGE (4.768). MLYS has higher annual earnings (EBITDA): -201.44M vs. APGE (-241.42M). APGE has more cash in the bank: 513M vs. MLYS (343M). APGE (0) and MLYS (0) have equivalent revenues.
APGEMLYSAPGE / MLYS
Capitalization2.77B948M292%
EBITDA-241.42M-201.44M120%
Gain YTD4.76818.11526%
P/E RatioN/AN/A-
Revenue00-
Total Cash513M343M150%
Total Debt11.8MN/A-
TECHNICAL ANALYSIS
Technical Analysis
APGEMLYS
RSI
ODDS (%)
Bearish Trend 4 days ago
75%
Bullish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
88%
Declines
ODDS (%)
Bearish Trend 19 days ago
78%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
75%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWHTX33.550.55
+1.67%
Nationwide Bailard Tech & Sci R6
LGOPX26.070.31
+1.20%
Lord Abbett Growth Opportunities P
GTSYX31.540.34
+1.09%
Invesco Small Cap Growth Y
RESGX16.130.10
+0.62%
Glenmede Environmental Accountability
MUTHX26.870.10
+0.37%
Franklin Mutual Shares Z

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+7.08%
SYRE - APGE
54%
Loosely correlated
+1.68%
CRNX - APGE
53%
Loosely correlated
+1.22%
ATXS - APGE
52%
Loosely correlated
+1.40%
ERAS - APGE
51%
Loosely correlated
-0.69%
KRYS - APGE
51%
Loosely correlated
+1.22%
More

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with PTGX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
+1.68%
PTGX - MLYS
50%
Loosely correlated
+0.71%
BIESF - MLYS
45%
Loosely correlated
N/A
XERS - MLYS
39%
Loosely correlated
+0.42%
ACLX - MLYS
36%
Loosely correlated
+1.24%
APGE - MLYS
35%
Loosely correlated
+7.08%
More